Calprotectin as a Biomarker for Infectious Diseases: A Comparative Review with Conventional Inflammatory Markers
International Journal of Molecular Sciences · 04.07.2025 · 26 (13) · 6476
DOI: 10.3390/ijms26136476 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.07.2025. Verfasst von Kristina Sejersen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Uppsala University, Uppsala University Hospital, 75185 Uppsala, Sweden. Hauptthemen laut MEDLINE: Leukocyte L1 Antigen Complex, Biomarkers, Inflammation, Communicable Diseases. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Calprotectin, the most abundant cytosolic protein in neutrophils, is a S100A8/S100A9 heterodimer released during immune activation. It inhibits bacterial growth by binding to essential metal ions and contributes to inflammation and leukocyte migration. This review highlights calprotectin’s potential as a diagnostic marker for bacterial infections and inflammation. Clinical trials demonstrate that calprotectin is at least as effective as C-reactive protein, procalcitonin, and white blood cell counts in predicting bacterial infections. The rapid elevation of calprotectin levels in the early stages of sepsis, pneumonia, brain injury, and transplant complications underscores its diagnostic value. Predictive use of calprotectin may reduce ICU stays, mortality, and costs. However, challenges remain, including assay standardization and bacterial–viral differentiation. Advanced methods, such as the particle-enhanced turbidimetric immunoassay, enable faster and more reliable measurements. While calprotectin shows promise, further standardization and clinical validation are necessary to optimize its diagnostic utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences, Uppsala University, Uppsala University Hospital, 75185 Uppsala, Sweden.
- Unilabs AB, 17154 Stockholm, Sweden.
- Department of Surgical Sciences, Uppsala University, Uppsala University Hospital, 75185 Uppsala, Sweden.
- NOVA Medical School, New University of Lisbon, 1099-085 Lisbon, Portugal.
ORCID-Profile: Kristina Sejersen, Mats B Eriksson, Anders O Larsson
Zitieren
APA
Sejersen, K., Eriksson, M. B., & Larsson, A. O. (2025). Calprotectin as a Biomarker for Infectious Diseases: A Comparative Review with Conventional Inflammatory Markers. International Journal of Molecular Sciences, 26(13), 6476. https://doi.org/10.3390/ijms26136476
Vancouver
Sejersen K, Eriksson MB, Larsson AO. Calprotectin as a Biomarker for Infectious Diseases: A Comparative Review with Conventional Inflammatory Markers. International Journal of Molecular Sciences. 2025;26(13):6476. doi:10.3390/ijms26136476
BibTeX
@article{Sejersen2025,
author = {Sejersen, Kristina and Eriksson, Mats B and Larsson, Anders O},
title = {Calprotectin as a Biomarker for Infectious Diseases: A Comparative Review with Conventional Inflammatory Markers},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {13},
pages = {6476},
doi = {10.3390/ijms26136476}
}
EUVIMED